ID

26045

Description

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Pharmacokinetics - Repeating form (Scheduled visits)

Keywords

Versions (4)
  1. 10/5/17 10/5/17 -
  2. 10/16/17 10/16/17 -
  3. 10/23/17 10/23/17 -
  4. 1/3/18 1/3/18 -
Copyright Holder

GlaxoSmithKline

Uploaded on

October 5, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

  • Newest
  • Oldest
  • Popular
  • Newest
    • Newest
    • Oldest
    • Popular

No comments

In order to download data models you must be logged in. Please log in or register for free.

Pharmacokinetics GSK study Chronic Coronary Heart Disease NCT00799903

English

Pharmacokinetics GSK study Chronic Coronary Heart Disease NCT00799903

1 forms  
An unscheduled PK blood sample must be obtained within 72 hours of last dose
Description

An unscheduled PK blood sample must be obtained within 72 hours of last dose

1. Was a pharmacokinetic blood sample obtained?
Description

pharmacokinetic blood sample

Data type

boolean

If yes, date taken
Description

Date of blood sample

Data type

date

If yes, time taken
Description

Time of blood sample

Data type

time

If Yes, date of last investigational product dose prior to PK sample
Description

date of last investigational product dose prior to PK sample

Data type

date

If Yes, time of last investigational product dose prior to PK sample
Description

time of last investigational product dose prior to PK sample

Data type

time

Sample Identifier/Sample Number
Description

Sample Identifier and Sample Number are conditional. The study team must choose one for inclusion on the eCRF form.

Data type

text

Back to the top of the page

Similar models

Pharmacokinetics GSK study Chronic Coronary Heart Disease NCT00799903

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
An unscheduled PK blood sample must be obtained within 72 hours of last dose
pharmacokinetic blood sample
Item
1. Was a pharmacokinetic blood sample obtained?
boolean
Date of blood sample
Item
If yes, date taken
date
Time of blood sample
Item
If yes, time taken
time
date of last investigational product dose prior to PK sample
Item
If Yes, date of last investigational product dose prior to PK sample
date
time of last investigational product dose prior to PK sample
Item
If Yes, time of last investigational product dose prior to PK sample
time
Sample Identifier/Sample Number
Item
Sample Identifier/Sample Number
text
Back to the top of the page 

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial